Hendley & CO Inc Gilead Sciences, Inc. Transaction History

Hendley & CO Inc

$287 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $235,850 - $295,545	-4,072 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $35,359 - $40,133	-545 Reduced 11.8%	4,072 $296,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $32,052 - $35,021	-505 Reduced 9.86%	4,617 $318,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $21,900 - $24,987	-365 Reduced 6.65%	5,122 $331,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $313,841 - $357,607	-5,540 Reduced 50.24%	5,487 $320,000
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $24,840 - $31,232	-400 Reduced 3.5%	11,027 $697,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $23,510 - $27,300	-325 Reduced 2.77%	11,427 $879,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $7,139 - $9,145	-114 Reduced 0.96%	11,752 $879,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $50,220 - $55,240	-815 Reduced 6.43%	11,866 $771,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $32,192 - $35,535	-515 Reduced 3.9%	12,681 $804,000
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $14,972 - $16,789	242 Added 1.87%	13,196 $892,000
Q1 2019 May 20, 2019	SELL	$62.53 - $70.05 $28,138 - $31,522	-450 Reduced 3.36%	12,954 $842,000
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $559,086 - $729,565	-9,235 Reduced 40.79%	13,404 $838,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $13,899 - $15,389	-195 Reduced 0.85%	22,639 $1.75 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $17,517 - $20,433	-270 Reduced 1.17%	22,834 $1.62 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $53,901 - $65,712	-740 Reduced 3.1%	23,104 $1.74 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $109,215 - $128,203	-1,535 Reduced 6.05%	23,844 $1.71 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $1.83 Million - $2.17 Million	25,379	25,379 $2.06 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.87 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.4 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hendley & CO Inc with notifications on news.

Account